How much does Axim Biotechnologies stock cost?
One share of AXIM stock can currently be purchased for approximately $0.16. How many employees does AXIM Biotechnologies have? AXIM Biotechnologies employs 7 workers across the globe.
Will Axim outperform or underperform the S&P 500 over the long term?
Vote “Outperform” if you believe AXIM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AXIM will underperform the S&P 500 over the long term. You may vote once every thirty days.
Who are Axim’s new advisory board members?
He joins AXIM’s four other Advisory Board members including Drs. Kelly K. Nichols, Henry D. Perry, Laura Periman, and its Chairman Joseph Tauber. Dr. Stern brings over
How has AXIM Biotechnologies' stock price performed in 2022?
AXIM Biotechnologies' stock was trading at $0.4330 at the beginning of the year. Since then, AXIM stock has decreased by 78.8% and is now trading a...
Are investors shorting AXIM Biotechnologies?
AXIM Biotechnologies saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 74,600 shares, an...
Who are AXIM Biotechnologies' key executives?
AXIM Biotechnologies' management team includes the following people: Mr. John W. Huemoeller II , Pres, CEO & Director (Age 67, Pay $420k) Mr. Ro...
Who are some of AXIM Biotechnologies' key competitors?
Some companies that are related to AXIM Biotechnologies include 3SBio (TRSBF) , 45525 (CUR.TO) (CUR) , Abattis Bioceuticals (ATTBF) , Abcam (AB...
What other stocks do shareholders of AXIM Biotechnologies own?
Based on aggregate information from My MarketBeat watchlists, some companies that other AXIM Biotechnologies investors own include (CGC) , Crono...
What is AXIM Biotechnologies' stock symbol?
AXIM Biotechnologies trades on the OTCMKTS under the ticker symbol "AXIM."
How do I buy shares of AXIM Biotechnologies?
Shares of AXIM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is AXIM Biotechnologies' stock price today?
One share of AXIM stock can currently be purchased for approximately $0.09.
How many employees does AXIM Biotechnologies have?
AXIM Biotechnologies employs 6 workers across the globe.
How has AXIM Biotechnologies' stock been impacted by COVID-19?
Who are some of AXIM Biotechnologies' key competitors?
AXIM Biotechnologies' stock was trading at $0.1781 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AXIM shares have increased by 12.3% and is now trading at $0.20. View which stocks have been most impacted by COVID-19.
What other stocks do shareholders of AXIM Biotechnologies own?
Some companies that are related to AXIM Biotechnologies include (TNGN) (TNGN), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abcam (ABCZF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), ALK-Abello A/S (AKBLF), Almirall (LBTSF), Amarantus BioScience (AMBS) and Amplia Therapeutics (ATX). View all of AXIM's competitors..
What is AXIM Biotechnologies' stock symbol?
Based on aggregate information from My MarketBeat watchlists, some companies that other AXIM Biotechnologies investors own include (CGC), Cronos Group (CRON), (APHA), Tilray (TLRY), KushCo (KSHB), Aurora Cannabis (ACB), Curaleaf (CURLF), Charlotte's Web (CWBHF), Fulcrum Therapeutics (FULC) and Alibaba Group (BABA).
How do I buy shares of AXIM Biotechnologies?
AXIM Biotechnologies trades on the OTCMKTS under the ticker symbol "AXIM."
What is AXIM Biotechnologies' stock price today?
Shares of AXIM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Signals & Forecast
One share of AXIM stock can currently be purchased for approximately $0.20.
Support, Risk & Stop-loss
A buy signal was issued from a pivot bottom point on Friday, February 11, 2022, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Is AXIM Biotechnologies, Inc. stock A Buy?
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
Insiders are very negative
AXIM Biotechnologies, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
About AXIM Biotechnologies, Inc
In the last 16 trades there were 19.22 million shares bought and 20 million shares sold. The last trade was done 1 427 days ago by Malasek Robert who bough 50 thousand shares.
Golden Star Signal
AXIM Biotechnologies, Inc., a preclinical stage research and development company focuses on changing diagnosis and treatment for oncology and SARS-CoV-2 (COVID-19).
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
